...
首页> 外文期刊>Clinical and experimental allergy : >MALDI-TOF MS analysis of labile Lolium perenne major allergens in mixes.
【24h】

MALDI-TOF MS analysis of labile Lolium perenne major allergens in mixes.

机译:MALDI-TOF MS分析的混合中的标题过敏原。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: It is well known that allergen extracts used for specific therapy of allergic disorders are commonly stored as mixtures, causing an alteration of its stability. OBJECTIVE: The aim of this report is to identify pollen allergens susceptible to degradation during storage of mixtures containing different sources of proteases in the absence of glycerol as a preserving agent. METHODS: Mixes containing Lolium perenne (Lol p) pollen extract with either Aspergillus fumigatus or Periplaneta americana extracts were prepared and co-incubated for 90 days at 4 degrees C. Samples were taken off at fixed times and comparatively tested by in vitro and in vivo assays with atopic patients. Selected pollinic allergens were subjected to MALDI-TOF MS analysis. RESULTS: ELISA inhibition evidenced the loss of potency from ryegrass extract, and immunoblotting assays showed the degradation of specific pollinic allergens during storage of mixtures containing protease-rich sources. An in vivo intradermal skin assay confirmed the gradual loss of the biological activity of L. perenne pollen extract co-incubated with non-related protease-rich extracts in comparison with that of the control pollen extract. MALDI-TOF MS analysis allowed us to determine that Lol p 1 and Lol p 5 are susceptible to proteolysis whereas Lol p 4 was found to be resistant to degradation during storage. CONCLUSIONS: Lol p 1 and Lol p 5 degradation is responsible for the loss of the biological activity of L. perenne pollen extract when co-incubated with protease-rich fungal and cockroach extracts in the same vial for months in the absence of glycerol as a preserving agent. The integrity of these major allergens must be preserved to increase the vaccine stability and to assure efficacy when mixes are used for immunotherapy.
机译:背景:众所周知,用于对过敏性疾病的特异性治疗的过敏原提取物通常储存为混合物,导致其稳定性的改变。目的:本报告的目的是鉴定在不存在甘油的情况下储存含有不同蛋白酶源的混合物期间易受降解的花粉过敏原。方法:制备含有Lolium Perenne(LOL P)花粉提取物的混合物,用曲霉菌或Periplaneta Americana提取物,并在4℃下将90天共培养90天。在固定时间下取出样品并通过体外和体内进行比较测试。与特应患者的测定。对选定的粉碎过敏原进行MALDI-TOF MS分析。结果:ELISA抑制证明了Ryegrass提取物的效力丧失,免疫印迹测定显示出在含蛋白酶富含蛋白酶的混合物期间特异性粉碎机过敏原的降解。体内皮肤鱼皮肤检测证实,与对照花粉提取物的富含非相关蛋白酶的提取物共孵育的L. perenne花粉提取物的生物活性逐渐丧失。 MARDI-TOF MS分析允许我们确定LOL P 1和LOL P 5易受蛋白水解的影响,而LOL P 4被发现在储存期间耐降解。结论:LOL P 1和LOL P 5降解负责L. Perenne花粉提取物的生物活性丧失,当不存在甘油的情况下在同一小瓶中与蛋白酶的丰富的真菌和蟑螂提取物共孵育时保存代理。必须保留这些主要过敏原的完整性,以增加疫苗稳定性,并在混合物用于免疫疗法时确保功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号